recurrent Non-Squamous Non-Small Cell Lung Cancer

recurrent Non-Squamous Non-Small Cell Lung Cancer is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Indicated drugs

What you can answer from here — as of October 25, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for recurrent Non-Squamous Non-Small Cell Lung Cancer share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.

Create Account